City of Hope HomeDonateContact UsCalendarRequest InfoSubscribe e-Newsletter

City of Hope is a NCI-designated Comprehensive Cancer Center
Patients & PublicDiseases & ConditionsResearchHow to HelpAcademicMediaAbout Us










City of Hope Statement Regarding Appeal in Genentech Royalty Case



Contact: Kevin Koga
800.888.5323
media@coh.org  

DUARTE, Calif., April 24, 2008 -- The California Supreme Court today issued a decision upholding a 2002 jury verdict of $300.1 million in compensatory damages in favor of City of Hope, for Genentech, Inc.’s breach of a 1976 agreement in which City of Hope entrusted a groundbreaking invention to Genentech that launched the biotechnology industry.
 
The decision also reversed the jury’s verdict that Genentech breached a fiduciary duty to City of Hope and the jury’s award of $200 million in punitive damages.
 
“City of Hope is extremely pleased that the California Supreme Court followed sound legal precedent in ruling the jury’s verdict on compensatory damages was correct,” said Robert W. Stone, City of Hope general counsel. “While we are disappointed that the court did not agree with our position on fiduciary duty, we are delighted by the overall outcome.”
 
At the 2002 trial, the Los Angeles County Superior Court jury decided that Genentech breached a 1976 contract with, as well as its fiduciary duty to, City of Hope. Under the contract, City of Hope entrusted a still-confidential invention to Genentech, which agreed to develop, patent and exploit it for their mutual benefit in exchange for the payment of royalties. The invention, created by Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., is a broadly applicable method for producing human proteins through recombinant DNA technology. This method was used by Genentech and many other biotechnology companies in developing a number of important drug therapies, including synthetic human insulin. At the conclusion of the trial, the jury awarded City of Hope $300.1 million in compensatory damages.  In a second phase of the trial, the jury awarded City of Hope $200 million in punitive damages.
 
In 2004, the California Court of Appeal upheld the jury’s 2002 decision in its entirety.  Today’s decision from the California Supreme Court follows Genentech’s appeal of that ruling.
 
The verdict payment, when received, will be used to further City of Hope’s mission of conducting research to quickly and safely bring new lifesaving treatments to patients.
 
# # #

Home | Appointment Request | Donate | Contact Us | Site Map | Policies/Disclaimer/NPP    •   Copyright © 2008 City of Hope. All rights reserved
1500 East Duarte Road, Duarte, California 91010 • 626-256-HOPE (4673)